Skip to content
Coat of arms of Tanzania

National Institute for Medical Research (NIMR)

Advancing Health Research, Enhancing Life

NIMR

The National Institute for Medical Research (NIMR) disseminated on 22nd December 2025 research findings from the project titled Genomic characterization of Acute Respiratory Infections (ARI) Pathogens in Tanzania at the Ministry of Health (MOH) in Mtumba, Dodoma. The event was graced by the Acting DPS Dr Vida Mbaga together with heads of sections in surveillance from the MoH, representatives from ILI/SARI sentinel sites, National Public Health Laboratory (NPHL) and the US Centres for Disease Control and Prevention (CDC) Tanzania underscoring the importance of multisectoral collaboration in addressing public health priorities.
Presenting the most salient findings, Dr Juma Kisuse, representing NIMR, presented that the study applied targeted Next-Generation Sequencing (tNGS) technology to comprehensively profile circulating respiratory pathogens and their associated antimicrobial resistance (AMR) genes. A total of 484 samples were randomly selected from the national ILI/SARI surveillance system and analyzed, covering the period from October 2023 to September 2024 across five geographical zones: Northern, Lake, Central, Coastal, and Southern Highlands. The study revealed a predominance of bacterial pathogens, dominated by Streptococcus mitis, Streptococcus pneumoniae, and Haemophilus influenzae, compared to the most commonly viruses reported.
The findings further revealed a high burden of bacterial and viral co-infections, with 89.5% of patients harbouring 2-14 pathogens. Thirty percent of patients exhibited mixed bacterial and viral co-infections, underscoring the complexity of diagnosis and management of ARI. Moreover, bacterial pathogens circulated year-round with clear peaks in June to December while viral pathogens showed sharper pathogen-specific peaks – CMV in March, Adenovirus in May, and SARS-CoV-2 in January/September. The study findings further indicated a high prevalence of Antimicrobial Resistance (AMR) Genes associated with Doxycycline, Beta-lactamases and Sulphonamides.
In concuding remarks, NIMR DG, Prof Said Aboud commented that Streptococcus mitis, S pneumoniae and H influenzae infections were more frequent than viruses demonstrating a shift in trend from viruses to bacteria. He commented on the importance to strengthen immunization against Haemophilus influenza type b which is part of penta 5. He remarked to broaden the scope of ARI surveillance from current SARS Cov-2 and influenza virus to detect more pathogens with more possible use of tNGS in order to guide the interventions on ARI. Furthermore, he thanked the entire study team – Dr Mary Mayige, Dr Clara Lubinza, Dr Gibson Kagaruki, Sudi Lwitiho and Dr Seth Misago.

Section Title

NIMR kupitia PEN-Plus Yafikisha Huduma za Magonjwa Yasiyoambukiza Karibu na Wananchi

Taasisi ya Taifa ya Utafiti wa Magonjwa ya Binadamu (NIMR) kupitia mradi wa utafiti wa PENPLUS imeendelea kuboresha utoaji wa huduma za magonjwa yasiyoambukiza nchini kwa kuwezesha Hospitali za Kondoa...

NIMR CONTINUES TO STRENGTHEN ETHICAL AND REGULATORY FRAMEWORK FOR TRADITIONAL MEDICINE RESEARCH IN TANZANIA

The National Institute for Medical Research (NIMR) has launched stakeholders’ consultation on draft Traditional Medicine Research Guidelines aimed at strengthening ethical and regulatory...

ELEVATING CLINICAL TRIAL OVERSIGHT IN AFRICA: TRACE TRAINING IN PROGRESS IN MOROGORO

Reviewers from regulatory and research institutions are currently gathered at the EDEMA Conference Hall in Morogoro for the Clinical Trial Reviewers Training (17–19 June 2026) under the TRACE...

Strengthening Africa’s Clinical Research Systems: NIMR Leads TRACE Training to Enhance Trial Oversight.

Waziri wa Afya, Mhe. Mohamed Mchengerwa, ameipongeza Taasisi ya Taifa ya Utafiti wa Magonjwa ya Binadamu (NIMR) kwa mchango wake mkubwa katika kufanya tafiti na ubunifu unaoendelea kuboresha matibabu...

Waziri Mchengerwa Aipongeza NIMR kwa Tafiti Zinazoimarisha Huduma za Afya na Kuchochea Maendeleo ya Taifa

Waziri wa Afya, Mhe. Mohamed Mchengerwa, ameipongeza Taasisi ya Taifa ya Utafiti wa Magonjwa ya Binadamu (NIMR) kwa mchango wake mkubwa katika kufanya tafiti na ubunifu unaoendelea kuboresha matibabu...

Mchengerwa Aitaka NIMR Kuharakisha Ugeuzaji wa Tafiti Kuwa Uchumi Halisi

Taasisi ya Taifa ya Utafiti wa Magonjwa ya Binadamu (NIMR) imeendelea kuimarisha mfumo wa usimamizi wa fedha kwa kuendesha zoezi la kuandaa hesabu za miezi tisa kwa mwaka wa fedha 2025/2026, hatua...

NIMR YAONGEZA KASI YA UWAJIBIKAJI KUPITIA UANDAAJI WA HESABU ZA MIEZI TISA KWA MWAKA WA FEDHA 2025/2026.

Taasisi ya Taifa ya Utafiti wa Magonjwa ya Binadamu (NIMR) imeendelea kuimarisha mfumo wa usimamizi wa fedha kwa kuendesha zoezi la kuandaa hesabu za miezi tisa kwa mwaka wa fedha 2025/2026, hatua...

NIMR Yawajengea Uwezo Watumishi Wake Kupitia Mafunzo ya Kitaaluma

Taasisi ya Taifa ya Utafiti wa Magonjwa ya Binadamu (NIMR) imeendelea kuonesha dhamira yake ya kuwekeza katika maendeleo ya rasilimali watu kwa kushiriki Mkutano wa 13 wa Kitaaluma wa Chama cha...

NIMR Yaandaa Mpango wa Manunuzi 202627 kwa Lengo la Kuimarisha Ufanisi na Tija

Taasisi ya Taifa ya Utafiti wa Magonjwa ya Binadamu (NIMR) imeandaa Mpango wa Manunuzi kwa mwaka wa fedha 2026/27, hatua inayolenga kuongeza ufanisi katika manunuzi ya umma na kuhakikisha utekelezaji...

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Dira 2050